Johnson & Johnson (JNJ) Net Income - Minority (2010)
Johnson & Johnson's (JNJ) quarterly Net Income - Minority came in at -$590.0 million in Q1 2010.
Johnson & Johnson (JNJ) Net Income - Minority (2010) Analysis & Trends
Johnson & Johnson has disclosed Net Income - Minority across 1 years of filings, most recently posting -$590.0 million for Q1 2010.
- Net Income - Minority for Q1 2010 came in at -$590.0 million, changed N/A year-over-year; the trailing twelve-month figure through Jan 2010 was -$590.0 million (changed N/A YoY), and the FY2010 annual result was -$590.0 million, changed N/A from the prior year.
- Net Income - Minority came in at -$590.0 million for Q1 2010 at Johnson & Johnson.
- In the past five years, Net Income - Minority ranged from a high of -$590.0 million in Q1 2010 to a low of -$590.0 million in Q1 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income - Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | - |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | - |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | - |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | - |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | - |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | - |
| 10 | Novartis Ag | 109.78 Bn | 109.09 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 3, 2010 | -590.00 Mn |